Abstract: A lead distal tip for a pacemaker includes a lead body including an insulated wire having a diameter of 2 French or less. The small size and flexibility of the lead distal tip and lead body reduce penetration and dislodgement risk for the lead distal tip. The lead distal tip can be delivered using a delivery catheter engaging with features on the lead distal tip to allow for the guidance and securement of the lead distal tip, despite its small and flexible nature. The attachment of the lead distal tip to heart tissue can be achieved by extending a linear member and/or a helical member from an end of the lead distal tip using features provided on the delivery catheter.

Abstract: Leadless pacemakers and methods of implanting the same are provided for a cardiac conduction system. A leadless pacemaker includes an implantable housing including a mounting interface, an electronic circuitry and a power source received by the implantable housing, and an electrode system connected to the electronic circuitry via the mounting interface. The electrode system includes electrodes configured to insert into a septum and having a length to reach pathways of the cardiac conduction system.

Abstract: A lead for cardiac conduction system includes a proximal end, a lead body extending from the proximal end, and a distal end extending from the lead body. The lead body includes a non-conductive spacer. The distal end includes a helix electrode distal to the spacer. The lead further includes a ring electrode proximal to the spacer and surrounding a portion of the lead body. The helix electrode includes a core disposed within a helical space of the helix electrode. Another lead for cardiac conduction system includes a proximal end, a lead body extending from the proximal end, and a distal end extending from the lead body. The distal end includes a first helix electrode extending from the lead body and a second helix electrode extending from the lead body. A tip of the first helix electrode is distal to a tip of the second helix electrode.

Abstract: A lead for a cardiac conduction system. The lead includes a lead body; a distal end including a first electrode configured to be inserted into a portion of a ventricular septum; a second electrode coupled to the lead body; a fixation element configured to fix the lead to the portion of the ventricular septum; and a proximal end. The lead further includes a shocking coil coupled to the lead body and spaced away from the second electrode.

Abstract: Systems and methods for determining parameters and/or configurations for implantable pulse generator and/or lead(s) for the cardiac conduction system. The method includes configuring a stimulation vector. The method also includes configuring an AV delay to be less than an intrinsic AV delay, controlling a pulse generator to deliver pacing with a pacing amplitude, determining a sensing signal from artifacts of the pacing, adjusting the pacing amplitude based on the determined sensing signal and a capture signal, and determining the pacing threshold based on the adjusted pacing amplitude. The method further includes configuring the AV delay to a percentage of an intrinsic AV delay, controlling the pulse generator to deliver pacing with the AV delay, determining a sensing signal from artifacts of the pacing, adjusting the AV delay based on the determined sensing signal, and configuring the pulse generator with the adjusted AV delay.

Abstract: A thin film solar cell structure and method of fabricating a thin film solar cell structure. The thin film solar cell structure comprises a photoelectric conversion structure; a grating coupler for coupling incident light into the photoelectric conversion structure; and a resonator structure for providing a light trapping in the photoelectric conversion structure.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: An assembly includes an introducing assembly having an elongate tubular sheath which has an external diameter. The sheath, which extends from a distal end to a proximal end, has a bore including an internal diameter sized to receive a dilator therethrough. The sheath includes a movable suture sleeve thereon. A method includes inserting an introducing assembly into a living body, and sliding a protector over a portion of the instrument and into a costoclavicular space.

Abstract: An assembly includes an introducing assembly having an elongate tubular sheath which has an external diameter. The sheath, which extends from a distal end to a proximal end, has a bore including an internal diameter sized to receive a dilator therethrough. The sheath includes a movable suture sleeve thereon. A method includes inserting an introducing assembly into a living body, and sliding a protector over a portion of the instrument and into a costoclavicular space.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: A method and apparatus for delivering anti-tachycardia pacing in an adaptive manner is disclosed. A cardiac rhythm management device, such as an implantable pacemaker, having anti-tachycardia pacing capability delivers anti-tachycardia pacing therapy in accordance with a selected pacing protocol upon detection of a terminable arrhythmia. The protocol is selected from a library of available protocols. A record of the successes and failures of each available protocol in converting tachyarrhythmias is maintained in a result table for use in selecting the protocol.

Abstract: An implantable cardioverter/defibrillator with antitachycardia pacing capability and method for operating same in which the detection zone boundary used to discriminate between tachycardia and fibrillation is adaptively adjusted based upon operating experience. Rate zones are provided for further classifying detected episodes of tachycardia and fibrillation according to the certainty of their being correctly identified based upon past operating experience. Adjustments of the rate zones and the fibrillation detection zone boundary are made based upon the results of antitachycardia pacing in attempting to terminate arrhythmic episodes.